Sanofi Pasteur, TIV + H1N1, Pediatric Population
Condition:   InfluenzaInterventions:   Biological: Inactivated H1N1 Vaccine;   Biological: Trivalent Inactivated Influenza VaccineSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified December 2010 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2009 Category: Research Source Type: clinical trials

Sanofi Pasteur, TIV + H1N1, Pediatric Population
Condition:   InfluenzaInterventions:   Biological: Trivalent Inactivated Influenza Vaccine;   Biological: Inactivated H1N1 VaccineSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified December 2010 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2009 Category: Research Source Type: clinical trials

Sanofi Pasteur, TIV + H1N1, Pediatric Population
Condition:   InfluenzaInterventions:   Biological: Inactivated H1N1 Vaccine;   Biological: Trivalent Inactivated Influenza VaccineSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified December 2010 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2009 Category: Research Source Type: clinical trials